Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/1800
Full metadata record
DC FieldValueLanguage
dc.contributor.authorREG. NO:BH0121015-
dc.date.accessioned2025-04-27T08:10:25Z-
dc.date.available2025-04-27T08:10:25Z-
dc.date.issued2024-
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/1800-
dc.description.abstractBackground: Iodine has been a cornerstone in antiseptic wound care for over a century. Lugol's solution is the basic form of iodine but has notable drawbacks such as stinging and caustic properties. Advances in wound management have led to the development of iodine complexes like povidone iodine (PI) and cadexomer iodine (CI), which offer controlled iodine release, enhancing their safety and efficacy. In the Indian context, diabetic ulcers are a significant health burden, necessitating effective and tailored treatment strategies. This study aims to compare the efficacy of cadexomer iodine ointment and povidone iodine ointment in the management of diabetic ulcers, focusing on wound healing, infection control, and patient outcomesen_US
dc.language.isoen_USen_US
dc.publisherKLE Academy of Higher Education and Research, Belagavien_US
dc.subjectCadexomer iodine, Povidone iodine, Diabetic ulcers, Wound healing, Randomized controlled trial, Wound management.en_US
dc.titleCadexomer iodine ointment vs povidine Iodine ointment in diabetic ulcer Dressing-a randomised control trial at a Teritiary care centeren_US
dc.typeDissertationsen_US
Appears in Collections:General Surgery MS

Files in This Item:
File Description SizeFormat 
BH0121015.pdf3.23 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.